id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1947971,ae969924-4806-4751-b10c-6a0f788dc66e,Q1,NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION,401103538,NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION,2017,first_quarter,MED,Increase funding for labs for Zika research,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2017-03-27T15:04:52.147000-04:00
1948153,174d8dd8-864c-42d2-8c9a-992750085c8f,Q1,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2017,first_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2017-04-01T14:01:07.030000-04:00
1948240,91896555-9496-4490-9fde-4e096776e11e,Q1,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2017,first_quarter,MED,Legislation related to Alzheimer's disease research.,"HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2017-04-02T20:43:58.793000-04:00
1948272,f585b3d8-d561-4e06-b1c0-e2b67afe3d96,Q1,WAKE FOREST UNIVERSITY HEALTH SCIENCES,6781,WAKE FOREST UNIVERSITY HEALTH SCIENCES,2017,first_quarter,MED,VA Research funding,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2017-04-03T10:50:51.617000-04:00
1948601,3cbb2c51-8b95-4552-98aa-c628f477201d,Q1,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2017,first_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,128375,0,0,2017-04-04T14:35:58.480000-04:00
1948679,ecf24a5d-a25c-4e5a-8a35-b0854c270bb8,Q1,GRIZZLE COMPANY,16987,UNIVERSITY OF LOUISVILLE,2017,first_quarter,MED,Support reauthorization of the REACH program.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-04T17:16:21.873000-04:00
1948767,42abffbf-63b2-4c58-a0d9-e09e88b56c27,Q1,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2017,first_quarter,MED,Pharmaceutical labeling,Food & Drug Administration (FDA),18750,,0,0,2017-04-05T11:00:08.737000-04:00
1948928,4f1461c3-4309-430b-a5dd-979a5d02484a,Q1,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2017,first_quarter,MED,Funding for the USDA Agricultural Research Service human nutrition research centers in both the FY17 Agricultural Appropriations bill (currently PL 114-254) and FY18 Agricultural Appropriations bill.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-05T21:39:54.553000-04:00
1949250,89186a63-01e4-4505-bdd4-1f5627998c4e,Q1,LUCY CALAUTTI,401104011,CHILDREN'S HOSPITAL ASSOCIATION,2017,first_quarter,MED,Repeal and replace Affordable Care Act legislation; Medicaid funding; per capita caps in Medicaid.,SENATE,60000,,0,0,2017-04-07T11:39:15.717000-04:00
1949493,e6b40777-9bd8-42f0-8a5e-84cb31aa8610,Q1,ALZHEIMER'S FOUNDATION OF AMERICA,323158,ALZHEIMER'S FOUNDATION OF AMERICA,2017,first_quarter,MED,"S. 445 -  the Home Health Care Planning Improvement Act of 2017
S. 464 - Independence at Home Act of 2017
H.R. 1825, Home Health Care Planning Act","Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",,28000,0,0,2017-04-08T15:54:45.543000-04:00
1949510,7a66ea2d-cb47-40f7-87cd-c2414a4c1106,Q1,O'NEILL AND ASSOCIATES,73134,"POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)",2017,first_quarter,MED,Medicare advantage and health care reform,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-09T11:17:19.400000-04:00
1949576,9e81a0d6-7fe7-4aaf-b896-85bf1087a070,Q1,NATURAL RESOURCE RESULTS LLC,321555,SHINE MEDICAL TECHNOLOGIES,2017,first_quarter,MED,Support lifting cap on NNSA program for medical isotope production under AMIPA; support funding SHINE facility under same program at NNSA in FY17 approps and FY18 budget and approps.,"Council on Environmental Quality (CEQ),Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office",20000,,0,0,2017-04-09T18:02:43.347000-04:00
1949682,1fd526d4-d854-4ad4-8bfd-900dca753c67,Q1,"THE CORMAC GROUP, LLC",66773,KESSLER FOUNDATION,2017,first_quarter,MED,"Appropriations, DOD, TBI Research, Veterans Issues","HOUSE OF REPRESENTATIVES,SENATE",34643,,0,0,2017-04-10T10:43:13.807000-04:00
1949741,6a26d7b1-3928-4739-ab5c-a207417bae20,Q1,UNIVERSITY OF MIAMI,39462,UNIVERSITY OF MIAMI,2017,first_quarter,MED,Defense Appropriation and Transportation,"Defense, Dept of (DOD)",,90500,0,0,2017-04-10T11:44:18.817000-04:00
1949833,6a40634b-e116-408c-90c9-43ce0c850b34,Q1,"THE CORMAC GROUP, LLC",66773,"HTG MOLECULAR DIAGNOSTICS, INC.",2017,first_quarter,MED,Medicare reimbursement issues for diagnostics,"HOUSE OF REPRESENTATIVES,SENATE",13016,,0,0,2017-04-10T13:21:49.973000-04:00
1949849,ced27e78-e66f-44a3-a3ec-7a04b9a1c7be,Q1,"THE CORMAC GROUP, LLC",66773,"MSLA, A MEDICAL CORPORATION",2017,first_quarter,MED,Health Care and Veterans Issues,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2017-04-10T13:34:02.940000-04:00
1950069,3efe08ae-eddb-4cd4-bcc1-655295bd296f,Q1,"THE PETRIZZO GROUP, INC.",305932,OMEROS CORPORATION,2017,first_quarter,MED,Advocated for Medicare packaged payment reform in Part B.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-10T21:35:57.193000-04:00
1950076,dbd3d832-9012-4a3d-8a0c-4fa719fa404c,Q1,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2017,first_quarter,MED,"Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-10T21:57:01.483000-04:00
1950089,dcc177fa-f7b0-4b01-96b9-abd8a0a26322,Q1,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2017,first_quarter,MED,Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-10T22:16:10.463000-04:00
1950112,31a889f3-463a-4fc6-b7f0-0026a3d13e3d,Q1,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2017,first_quarter,MED,Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases,"Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office",,52000,0,0,2017-04-11T09:24:38.817000-04:00
1950345,045ae1f1-0879-4755-aa32-94e444ff899d,Q1,HOLLAND & KNIGHT LLP,18466,THE BIOSIMILARS FORUM,2017,first_quarter,MED,"Medicare reimbursement issues, FDA regulation of biosimilars.","HOUSE OF REPRESENTATIVES,SENATE",120000,,0,0,2017-04-11T15:02:07.023000-04:00
1950434,1ada3bcf-2788-4db5-95a9-ff52f1848165,Q1,MCDERMOTT+ LLC,401103287,COALITION FOR 21ST CENTURY MEDICINE,2017,first_quarter,MED,Issues concerning regulation of laboratory-developed tests.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",80000,,0,0,2017-04-11T15:50:12.080000-04:00
1950449,ffe46337-89df-40ed-bf66-e47b4468909b,Q1,MAGNET STRATEGY GROUP,401104125,MEDICAGO INC.,2017,first_quarter,MED,Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease.,"HOUSE OF REPRESENTATIVES,SENATE",7000,,0,0,2017-04-11T15:59:26.857000-04:00
1950767,6f3772c1-3adc-41cf-af3c-4b8729224a59,Q1,"WILLIAMS AND JENSEN, PLLC",41454,VERTEX PHARMACEUTICALS INCORPORATED,2017,first_quarter,MED,Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-12T10:53:01.273000-04:00
1950771,9b3cf224-d063-408d-9bf0-322a9dd42fa2,Q1,"WILLIAMS AND JENSEN, PLLC",41454,BIOGEN IDEC,2017,first_quarter,MED,Prescription drug user fee agreements and general education about FDA approval polices and NIH research activities.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-12T10:53:02.930000-04:00
1950845,fee2d166-f914-4fd1-a40f-7eda163ce714,Q1,HACKENSACK MERIDIAN HEALTH,401104109,HACKENSACK MERIDIAN HEALTH,2017,first_quarter,MED,"National Institutes of Health funding
340B designation and funding
Behavioral health
Substance abuse, opioids, and patient data","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2017-04-12T11:27:38.157000-04:00
1950899,276a0531-9908-4cf5-977a-5552e86cc767,Q1,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2017,first_quarter,MED,"Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients.  Support appropriate funding for the ADAP program.","HOUSE OF REPRESENTATIVES,SENATE",36000,,0,0,2017-04-12T12:04:50.300000-04:00
1951241,7af56162-262c-4461-9af5-24cdfd4831f9,Q1,"TCH GROUP, LLC",51478,INTERNATIONAL AIDS VACCINE INITIATIVE,2017,first_quarter,MED,"FY 18 House and Senate State Foreign Operations Subcommittee Appropriations bill.  Specifically, continued Federal funding under US AID for AIDS vaccine research and development","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-12T16:45:41.527000-04:00
1951458,5cd95075-416d-455b-a4f1-ba4b6d4cdedb,Q1,"KD ADVOCACY AND CONSULTING, LLC",401103971,REACHING MILESTONES,2017,first_quarter,MED,Advocating to improve coverage and access to autism treatment services for TRICARE beneficiaries.,"Defense, Dept of (DOD)",,,0,0,2017-04-13T10:18:42.243000-04:00
1951657,1fd4d5da-eaef-464f-a22b-3fb15d33e7c0,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2017,first_quarter,MED,"Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.
HR 1301, FY 2017, Defense Appropriations, FY 2017 defense health program, Tuberous Sclerosis Complex Research Program","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2017-04-13T11:20:03.627000-04:00
1951699,9b94af2b-9474-49dc-93bc-9bdb82bb7dcf,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN BRAIN TUMOR ASSOCIATION,2017,first_quarter,MED,"FY 17, Defense Appropriations Act, cancer research, HR 1301
FY 17, Labor-HHS-Education Appropriations Act, S 3040/HR 5926 NIH, Cancer Research
FY 18, Defense Appropriations Act, cancer research","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2017-04-13T11:56:59.160000-04:00
1951719,c0af8e64-01cb-4c0b-835a-709189e9d79c,Q1,THE FRIEDLANDER GROUP,400535604,OHEL CHILDRENS HOME AND FAMILY SERVICES,2017,first_quarter,MED,Block Grants,"HOUSE OF REPRESENTATIVES,SENATE",7500,,0,0,2017-04-13T12:01:11.520000-04:00
1951730,66fc7700-8541-4434-a865-a59164352b1b,Q1,VAN FLEET ASSOCIATES,39781,BELLUS MEDICAL,2017,first_quarter,MED,FDA approval of medical devices,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-13T12:07:23.270000-04:00
1951832,ab8f02c4-20cf-4064-a35a-1171a672b7a9,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION,2017,first_quarter,MED,"Research opportunities at the Department of Defense and the Centers for Disease Control.
FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.
HR 1301, FY 2017, Defense Appropriations Act, defense health programs.
HR 1628, American Health Care Act, Medicaid and Essential Health Benefits","Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2017-04-13T13:01:47.350000-04:00
1951886,3e9da969-7ece-4c2f-b75e-3269e947b8f5,Q1,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2017,first_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,SENATE",,79049,0,0,2017-04-13T13:28:19.693000-04:00
1951942,dad18e77-b6ff-488a-bb38-423304dca8b9,Q1,"PUBLIC SPHERE, INC.",401104153,SI-BONE,2017,first_quarter,MED,General company overview for members and staff.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-13T13:44:56.227000-04:00
1952292,14b6f342-b675-4440-a7e9-34b76fb719e3,Q1,"CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.",401103415,"CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.",2017,first_quarter,MED,"Implementation of the 21st Century Cures Act, provisions related to pediatric training and research","HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,170000,0,0,2017-04-13T15:12:45.427000-04:00
1952400,15e1ba0f-f2d8-4873-96fb-85e46910bccc,Q1,LNE GROUP,308811,HOSPICE OF THE WESTERN RESERVE,2017,first_quarter,MED,Lobbied on issues related to medical/disease research.,"HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",10000,,0,0,2017-04-13T15:56:13.773000-04:00
1952561,afcdc2ac-dc5b-4c9d-a803-85d244e3d3c1,Q1,MICHAEL N. MCCARTY LAW OFFICE PLLC,401104300,AMERICAN MEDICAL TECHNOLOGISTS,2017,first_quarter,MED,Regulation of Laboratory Developed Tests; Funding for harmonization of diagnostic test results; personnel qualifications under the Clinical laboratory Improvement Amendments of 1988,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-13T17:54:26.497000-04:00
1952591,dc3e13cc-f6fb-4c43-ad45-288a554d7001,1T,GROUP HEALTH COOPERATIVE,17022,GROUP HEALTH COOPERATIVE,2017,first_quarter,MED,Health system and medical research topics.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE",,10000,0,1,2017-04-13T18:38:52.643000-04:00
1952678,d5f38ddb-27ec-4e39-a2e7-a28a6afd5427,Q1,"ROPES & GRAY, LLP",33682,MEDICAL INFORMATION WORKING GROUP,2017,first_quarter,MED,Potential FDA Regulations and Policies Affecting the Dissemination of Information by Pharmaceutical and Medical Device Manufacturers,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2017-04-14T09:43:01.897000-04:00
1952728,ed0f7acf-607b-418e-9d34-452b82766bad,Q1,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,312496,CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER,2017,first_quarter,MED,"NIH funding  HHS budget bill, PREA re-authorization","Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,68582,0,0,2017-04-14T10:48:35.123000-04:00
1953084,970fda91-170f-4d48-9cb7-8d9213154d19,Q1,"SAM ACTION, INC.",401104337,"SAM ACTION, INC.",2017,first_quarter,MED,"S. 3077[114] - MEDs Act, H.R. 5549[114] - Medical Marijuana Research Act, S. 683[114] - CARERS Act","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",,,0,0,2017-04-14T14:33:06.423000-04:00
1953303,93b96700-aa95-4ba0-a408-110c62189244,Q1,MR. BRIAN KELLY,40024191,INTELLIA THERAPEUTICS,2017,first_quarter,MED,Gene Editing,"Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office",15000,,0,0,2017-04-14T17:32:49.587000-04:00
1953308,8ca8e27c-24ac-4198-a085-8a70c6dddfc4,Q1,MR. BRIAN KELLY,40024191,LUNDBECK PHARMACEUTICALS,2017,first_quarter,MED,"Brain Disorders
CNS
Alzheimer's","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2017-04-14T17:36:52.507000-04:00
1953449,dc528784-70a6-438e-bc6d-101a7c3f962a,Q1,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2017,first_quarter,MED,Issues impacting hospitals,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-16T08:32:56.447000-04:00
1953579,2317e419-4258-4c1b-9bd4-8849d327ccb2,Q1,LNE GROUP,308811,PARKER HANNIFIN,2017,first_quarter,MED,Lobbied for issues related to medical research.,"HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2017-04-17T08:23:38.193000-04:00
1953870,08a34f50-438c-457a-85bb-5491a7c0ee72,Q1,"INTUITIVE SURGICAL, INC.",400670004,"INTUITIVE SURGICAL, INC.",2017,first_quarter,MED,comparative effectiveness research in healthcare,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2017-04-17T11:10:01.133000-04:00
1953884,a7d6673a-379c-4e79-92e7-27b4a3a57273,Q1,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),1466,ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC),2017,first_quarter,MED,AACC joined with other laboratory groups in writing to the Department of Health and Human Services seeking a delay in the laboratory reporting requirements under the Protecting Access to Medicare Act of 2014.,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,60000,0,0,2017-04-17T11:17:08.507000-04:00
1953917,6490999a-eefd-4210-9edb-dd8905f4166e,Q1,MARSHFIELD CLINIC HEALTH SYSTEM,57830,MARSHFIELD CLINIC HEALTH SYSTEM,2017,first_quarter,MED,"Protecting Access to Medicare Act of 2014 (PAMA)
PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS).  This rule for PAMA requires reporting of Clinical lab prices and volumes.  MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,100000,0,0,2017-04-17T11:26:27.917000-04:00
1954044,debc6849-ba80-4e3f-b01d-2d84067de5ad,Q1,THE O TEAM LLC,400783359,THE SUZANNE WRIGHT FOUNDATION,2017,first_quarter,MED,Pancreatic cancer awareness.,"HOUSE OF REPRESENTATIVES,SENATE",90000,,0,0,2017-04-17T12:09:45.357000-04:00
1954391,d133961c-ac51-4b1b-952b-90e506eb9965,Q1,NELSON MULLINS RILEY & SCARBOROUGH,285871,"NATERA, INC.",2017,first_quarter,MED,"Biomedical research, maternal health, and genetic testing","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-17T14:36:06.920000-04:00
1954735,f79fb37b-00c0-46e0-a9b7-7445ee594653,Q1,KASOWITZ LLP,401103221,SPECTRUM PHARMACEUTICALS,2017,first_quarter,MED,Regulation of the medical use of nuclear materials and its effect on cancer patient access.,"HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE",25000,,0,0,2017-04-17T16:01:05.947000-04:00
1954787,9b1bdd51-6141-447e-bd60-a8d834d21e1b,Q1,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2017,first_quarter,MED,Labor/HHS/Education Appropriation Bill: Provisions relating to disease research.,"Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE",50000,,0,0,2017-04-17T16:14:33.137000-04:00
1954824,1c814a9d-de58-4f46-b8b5-929043844f66,Q1,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2017,first_quarter,MED,"Labor/HHS/Education Appropriations Bill: Provisions relating to disease research, education  and development.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-17T16:23:48.637000-04:00
1955056,16ffe8fc-df69-47cd-b97c-2960e3c12a45,Q1,THORN RUN PARTNERS,400534596,CONTINUING MEDICAL EDUCATION COALITION,2017,first_quarter,MED,"Issues related to the promotion of continuing medical education and the implementation of the Physician Payment Sunshine Act.
Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-17T18:53:53.707000-04:00
1955076,55dcf13e-a9de-4575-ae30-1c5bc5da01fc,Q1,THORN RUN PARTNERS,400534596,NOVARTIS CORPORATION,2017,first_quarter,MED,Issues related to biologics.,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-17T19:41:35.027000-04:00
1955087,8c8937be-fd0b-4f56-9e90-9056db2e8fe7,Q1,BROYDRICK & ASSOCIATES,7268,EXACT SCIENCES,2017,first_quarter,MED,Legislation on cancer screening test process.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE",40000,,0,0,2017-04-17T19:52:50.497000-04:00
1955097,1aae401b-053d-4fdc-9396-1de663f38fb8,Q1,BROYDRICK & ASSOCIATES,7268,"MORTARA INSTRUMENTS, INC.",2017,first_quarter,MED,OFAC licensing. Vender-neutral procurement language. 21st Century cures and E.H.R.  Interoperability.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2017-04-17T20:04:05.497000-04:00
1955099,0b1ce3b3-eeb0-469f-b9d6-9e36f9bc0ba5,Q1,BROYDRICK & ASSOCIATES,7268,"NORTHSTAR RADIOISOTOPES, LLC",2017,first_quarter,MED,"DOE policies and cooperative agreements expansion legislation.  Nuclear medicine and CMS Reimbursement. NNSA reorganization, S512 Uranium production (2017).","Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2017-04-17T20:06:08.140000-04:00
1955157,4aa881b0-e0c6-42ac-a6c4-f5f4685fb0e1,Q1,THORN RUN PARTNERS,400534596,CHILDRENS HOSPITAL COLORADO,2017,first_quarter,MED,"H.R.1628, American Health Care Act of 2017.
Issues related to pediatric research and childrens hospital graduate medical education.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2017-04-17T22:09:02.293000-04:00
1955165,7403c54f-b236-456e-bdd1-c27cc5330399,Q1,THORN RUN PARTNERS,400534596,ABBVIE INC.,2017,first_quarter,MED,"Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding.","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2017-04-17T22:11:07.687000-04:00
1955168,8062ebdb-5ce9-439a-b585-e9e2c24f5d30,Q1,THORN RUN PARTNERS,400534596,ABBOTT LABORATORIES,2017,first_quarter,MED,"Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2017-04-17T22:13:08.997000-04:00
1955262,2a47d92e-983b-47b4-a5f2-a72fa5a4856e,Q1,THORN RUN PARTNERS,400534596,GLAUKOS CORPORATION,2017,first_quarter,MED,Issues related to medical technology used for the treatment of glaucoma.,,50000,,0,0,2017-04-18T00:31:01.623000-04:00
1955284,d58c3a31-6592-4df3-acd9-e9ace0a0c8b6,Q1,THORN RUN PARTNERS,400534596,HACKENSACK MERIDIAN HEALTH,2017,first_quarter,MED,"H.R.1628, American Health Care Act of 2017.
Issues relating to research funding, NIH and other matters.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-18T01:04:15.320000-04:00
1955337,5da88aa5-d7e6-4e1f-a9aa-970ae0135d31,Q1,SRI INTERNATIONAL,90990,SRI INTERNATIONAL,2017,first_quarter,MED,FY17 and FY18 Labor-HHS-Education Appropriations,"HOUSE OF REPRESENTATIVES,SENATE",,8000,0,0,2017-04-18T08:46:00.627000-04:00
1955481,7be822c9-127b-47ea-a2dc-e9330a34801e,Q1,JENNIE AYLWARD,401104208,PINK RIBBON RED RIBBON,2017,first_quarter,MED,Requested support for the U.S. Governments contributions to fight women's cancers in low- and middle-income countries with robust funding for the National Institutes of Health (especially the National Cancer Institute) in FY2018 Labor/HHS/Education appropriations.,"HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",,,0,0,2017-04-18T09:46:35.367000-04:00
1955502,9a4b826a-319d-4800-bd03-d401d366b03c,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,"23ANDME, INC.",2017,first_quarter,MED,"Direct to consumer genetic testing
Regulation and oversight of diagnostics
S. 2744, Genetic Research Privacy Protection Act
Public Law No. 44-255 21st Century Cures Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",20000,,0,0,2017-04-18T09:49:44.133000-04:00
1955512,73ef50d8-d72e-46d2-8670-4d5dc47cbe27,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,CURE FORWARD,2017,first_quarter,MED,"Cancer Moonshot
Patient Access to lab results
Public Law No. 144-255 21st Century Cures Act","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-18T09:52:55.367000-04:00
1955522,138bd8a8-247b-4e2d-b75e-3e2d0942cf31,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,COUNSYL,2017,first_quarter,MED,"Regulation and oversight of diagnostics
Reimbursement of diagnostics","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-18T09:56:02.633000-04:00
1955535,1e442d11-33be-49af-8a1c-2a16da2b205a,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY,2017,first_quarter,MED,Next generation sequencing based diagnostics,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-18T10:00:14.273000-04:00
1955602,ada714fd-44df-460d-8b5a-7c7f056ba6c7,Q1,FTI GOVERNMENT AFFAIRS,401054971,HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY,2017,first_quarter,MED,Monitor developments related to Electronic Health Records.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-18T10:20:13.480000-04:00
1955746,7903ac80-335c-4891-88e2-d1f472d09011,Q1,RAMPY NORTHRUP LLC,401103289,AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA),2017,first_quarter,MED,"Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services).
Policies impacting Medicare reimbursement for clinical laboratory services.
FDA regulation of clinical laboratory services.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2017-04-18T11:01:11.343000-04:00
1955816,149f5a47-3b5d-4cef-ac34-a70e96616e46,Q1,RAMPY NORTHRUP LLC,401103289,"ILLUMINA, INC.",2017,first_quarter,MED,"Legislation and regulation affecting the genetic sequencing industry and the use of genetic information in research and clinical settings. 
National Institutes of Health (NIH) funding.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2017-04-18T11:24:12.457000-04:00
1956428,8e91e125-6b02-4753-be46-3c938160df61,Q1,SMITHS GROUP SERVICES CORPORATION,290137,SMITHS GROUP SERVICES CORPORATION,2017,first_quarter,MED,Implementation of 21st Century Cures Act (P.L.114-255); issues related to patient infusion therapy. Regulations related to Medical Device User Fee Amendments (MDUFA). Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.,"Army, Dept of (Other),Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation Security Administration (TSA),U.S. Customs & Border Protection",,420000,0,0,2017-04-18T13:36:03.243000-04:00
1956466,5596d4c3-3d0e-4644-9592-4c930d6ab12c,Q1,INFECTIOUS DISEASES SOCIETY OF AMERICA,54836,INFECTIOUS DISEASES SOCIETY OF AMERICA,2017,first_quarter,MED,Medical liability; antimicrobial resistance research; infectious diseases product R&D; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policy to allow HIV+ to HIV+ organ transplants,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,110000,0,0,2017-04-18T13:43:24.713000-04:00
1956607,d33705ad-e39a-4f9c-94c4-af73aa8cc027,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ENDOCRINE SOCIETY,2017,first_quarter,MED,Research in Endocrinology; Public Law No. 114-255; 21st Century Cures bill,"Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2017-04-18T14:06:44.327000-04:00
1956781,9b23c0a2-a555-4ece-aa2e-78c095291618,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2017,first_quarter,MED,"Precision Medicine Initiative
Regulation of laboratory diagnostics
Cancer Moonshot","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office",60000,,0,0,2017-04-18T14:36:30.423000-04:00
1956792,1182c33a-4da7-44e3-aabe-97638756e8dd,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,ASSOCIATION FOR MOLECULAR PATHOLOGY,2017,first_quarter,MED,"Precision Medicine Initiative
Regulation of laboratory diagnostics
Cancer Moonshot","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office",60000,,0,0,2017-04-18T14:38:40.657000-04:00
1956947,807ff530-02b3-4010-9c22-0d89c6d61d6a,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,AMERICAN SOCIETY OF HEMATOLOGY,2017,first_quarter,MED,Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",30000,,0,0,2017-04-18T15:08:28.067000-04:00
1957008,a13e8a00-2924-49df-afd2-e589373cb016,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL HEMOPHILIA FOUNDATION,2017,first_quarter,MED,"Hemophilia research, prevention, surveillance and service programs and issues.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",50000,,0,0,2017-04-18T15:17:10.600000-04:00
1957030,261b521b-05c5-4c21-9511-f88e948eb20a,Q1,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,NATIONAL ASSOCIATION OF EPILEPSY CENTERS,2017,first_quarter,MED,Research and public health programs in epilepsy.,"Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",10000,,0,0,2017-04-18T15:20:23.850000-04:00
1957041,50e584b0-6750-4abf-94a7-f9831e90a214,Q1,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,401103605,PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION,2017,first_quarter,MED,"Reauthorization of the Generic Drug User Fee Amendments, and general education about the pharma/biopharma contract services sector.","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2017-04-18T15:22:35.380000-04:00
1957417,4a93a516-7e48-4877-a807-401ac9d71417,Q1,HOLLAND & KNIGHT LLP,18466,PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION,2017,first_quarter,MED,"Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; the FY 2017 & FY 2018 Ag-FDA Appropriations bill; nominations to HHS and FDA; House and Senate resolutions on sunscreen use in schools.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2017-04-18T16:19:12.777000-04:00
1957457,ef2c7ab7-cd1f-42b8-a33a-1de75e3e190b,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,ALLIANCE FOR BIOSECURITY,2017,first_quarter,MED,"S. 2055 Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; H.R. 34 21st Century Cures Act; H.R. 3299, Strengthening Public Health Emergency Response Act of 2016, provisions regarding priority review vouchers contracting.","Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",60000,,0,0,2017-04-18T16:28:39.217000-04:00
1957621,89386a63-9087-4b34-80b9-b7a9b0aa6a15,Q1,OGR,48827,SMITHS GROUP PLC,2017,first_quarter,MED,Medical device technology related to the opioid epidemic.,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-18T16:57:34.643000-04:00
1957757,ea3587aa-674c-4281-9cf3-ca45a0a64d9f,Q1,TRAVERE THERAPEUTICS,401104190,TRAVERE THERAPEUTICS,2017,first_quarter,MED,"Medical research, NIH funding, FDA personnel issues","HOUSE OF REPRESENTATIVES,SENATE",,140000,0,0,2017-04-18T17:38:39.677000-04:00
1957879,f4a96804-4fa9-42b6-b596-bc9e4755e480,Q1,STANFORD UNIVERSITY,36492,STANFORD UNIVERSITY,2017,first_quarter,MED,"American Healthcare Act

Health Professions Programs

Graduate Medical Education Funding

Pediatric GME Programs

Precision Medicine

Brain Initiative","Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE",,70000,0,0,2017-04-18T18:31:58.263000-04:00
1958011,43a811ee-0c0f-4659-89fa-605ef9da4d91,Q1,ISEMAN & ASSOCIATES LLC,401103582,"TICHENOR VENTURES, LLC",2017,first_quarter,MED,Monitoring biotech legislation,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2017-04-18T21:19:02.907000-04:00
1958230,cf5e1ff9-f21d-4371-b274-6b35d9982df7,Q1,CAPITOL COUNSEL LLC,313715,MASSACHUSETTS BIOTECHNOLOGY COUNCIL,2017,first_quarter,MED,Monitor health and tax legislation pertaining to the biotechnology industry.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-18T23:42:34.267000-04:00
1958358,5bf589c1-2a57-4cb3-9e70-92bb13052e79,Q1,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF NOTRE DAME,2017,first_quarter,MED,Zika virus research and development related issues,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2017-04-19T07:45:54.077000-04:00
1958524,e0d36037-cf28-4ec3-bc57-3f1a4a3a9563,Q1,MAYO CLINIC,400270238,MAYO CLINIC,2017,first_quarter,MED,American Health Care Act; Lab payments; Research Funding; Cancer Moonshot; Regulatory Relief,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Vice President of the U.S.,White House Office",,250000,0,0,2017-04-19T09:10:02.180000-04:00
1959199,fd80af4f-5837-4be4-861a-6725f335d697,Q1,FAEGRE DRINKER BIDDLE & REATH LLP,12631,AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE,2017,first_quarter,MED,Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel; Executive Order on Immigration and Refuges; Executive Order on federal government hiring freeze; H. Res. 165 a resolution in support of polio eradication.,"Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-19T10:51:04.863000-04:00
1959218,d6c9e1ed-257e-4284-ac7b-d75f1ca1c9e1,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,"MYRIAD GENETIC LABORATORIES, INC.",2017,first_quarter,MED,FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2017-04-19T10:53:15.723000-04:00
1959298,02c2ffae-b2e2-4d6d-ab75-576b55e3df7a,Q1,FAEGRE BAKER DANIELS CONSULTING,34158,USAGAINST ALZHEIMER'S,2017,first_quarter,MED,Alzheimer's Disease research,"Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2017-04-19T11:02:05.347000-04:00
1959489,4ec30183-aaa0-4176-a2d9-ba074874c34b,Q1,CORNELL UNIVERSITY,10877,CORNELL UNIVERSITY,2017,first_quarter,MED,"Met with legislative staff to express support for National Institutes of Health (see also Budget), support for the implementation of the Cures Act - including concerns that proposed budget cuts to NIH would cancel out increases to NIH budget provided in Cures Act.
Met with legislative staff to discuss the process of placing medical students from offshore medical schools in VA hospitals.","HOUSE OF REPRESENTATIVES,SENATE",,130000,0,0,2017-04-19T11:22:49.397000-04:00
1959721,f0be6781-0e27-4077-ab07-d1daf166e883,Q1,AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION FKA PROPERTY CASUALTY INSURERS ASSOC. OF AMERICA,26854,AMERICAN PROPERTY CASUALTY INSURANCE ASSOCIATION,2017,first_quarter,MED,"H.R. 1824Marijuana
H.R. 714Marijuana
H.R. 715Marijuana
H.R. 975Marijuana
S. 780Marijuana","HOUSE OF REPRESENTATIVES,SENATE",,1380000,0,0,2017-04-19T11:49:19.527000-04:00
1959833,de064e58-deae-4757-828f-0cba6542eee3,Q1,MONUMENT ADVOCACY,308775,GROUP HEALTH COOPERATIVE,2017,first_quarter,MED,Health systems and medical research topics,"HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE",10000,,0,0,2017-04-19T12:03:45.730000-04:00
1960397,0d00913e-87bf-4557-a2e2-b0009f6fae22,Q1,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2017,first_quarter,MED,"Support for all federal agencies that fund medical and disease research
FY 17 and FY 18 appropriations for HHS, NIH, CDC, and DOD","Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,86662,0,0,2017-04-19T13:22:00.943000-04:00
1960674,b716b932-49b3-4cae-ab47-4ead5dfb486a,Q1,AMERICAN ACADEMY OF PEDIATRICS,1397,AMERICAN ACADEMY OF PEDIATRICS,2017,first_quarter,MED,Drugs and Devices,"Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Justice, Dept of (DOJ),Natl Highway Traffic Safety Administration (NHTSA),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),White House Office",,90271,0,0,2017-04-19T13:54:01.307000-04:00